Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1947 1
1961 1
1965 1
1966 1
1967 1
1968 1
1973 1
1974 2
1975 1
1976 2
1977 1
1978 2
1979 1
1980 1
1982 1
1985 1
1986 4
1987 3
1988 5
1990 2
1991 4
1992 4
1994 2
1995 3
1996 3
1997 2
1998 6
1999 5
2000 4
2001 3
2002 6
2003 2
2004 7
2005 2
2006 2
2007 9
2008 7
2009 9
2010 6
2011 14
2012 4
2013 7
2014 6
2015 3
2016 8
2017 10
2018 15
2019 17
2020 9
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Results by year
Filters applied: . Clear all
Page 1
AZD4573 Is a Highly Selective CDK9 Inhibitor That Suppresses MCL-1 and Induces Apoptosis in Hematologic Cancer Cells.
Cidado J, Boiko S, Proia T, Ferguson D, Criscione SW, San Martin M, Pop-Damkov P, Su N, Roamio Franklin VN, Sekhar Reddy Chilamakuri C, D'Santos CS, Shao W, Saeh JC, Koch R, Weinstock DM, Zinda M, Fawell SE, Drew L. Cidado J, et al. Among authors: drew l. Clin Cancer Res. 2020 Feb 15;26(4):922-934. doi: 10.1158/1078-0432.CCR-19-1853. Epub 2019 Nov 7. Clin Cancer Res. 2020. PMID: 31699827 Free article.
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex.
Hsu JH, Rasmusson T, Robinson J, Pachl F, Read J, Kawatkar S, O' Donovan DH, Bagal S, Code E, Rawlins P, Argyrou A, Tomlinson R, Gao N, Zhu X, Chiarparin E, Jacques K, Shen M, Woods H, Bednarski E, Wilson DM, Drew L, Castaldi MP, Fawell S, Bloecher A. Hsu JH, et al. Among authors: drew l. Cell Chem Biol. 2020 Jan 16;27(1):41-46.e17. doi: 10.1016/j.chembiol.2019.11.004. Epub 2019 Nov 27. Cell Chem Biol. 2020. PMID: 31786184 Free article.
Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
Katayama R, Shaw AT, Khan TM, Mino-Kenudson M, Solomon BJ, Halmos B, Jessop NA, Wain JC, Yeo AT, Benes C, Drew L, Saeh JC, Crosby K, Sequist LV, Iafrate AJ, Engelman JA. Katayama R, et al. Among authors: drew l. Sci Transl Med. 2012 Feb 8;4(120):120ra17. doi: 10.1126/scitranslmed.3003316. Epub 2012 Jan 25. Sci Transl Med. 2012. PMID: 22277784 Free PMC article.
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies.
Barlaam B, Casella R, Cidado J, Cook C, De Savi C, Dishington A, Donald CS, Drew L, Ferguson AD, Ferguson D, Glossop S, Grebe T, Gu C, Hande S, Hawkins J, Hird AW, Holmes J, Horstick J, Jiang Y, Lamb ML, McGuire TM, Moore JE, O'Connell N, Pike A, Pike KG, Proia T, Roberts B, San Martin M, Sarkar U, Shao W, Stead D, Sumner N, Thakur K, Vasbinder MM, Varnes JG, Wang J, Wang L, Wu D, Wu L, Yang B, Yao T. Barlaam B, et al. Among authors: drew l. J Med Chem. 2020 Dec 24;63(24):15564-15590. doi: 10.1021/acs.jmedchem.0c01754. Epub 2020 Dec 11. J Med Chem. 2020. PMID: 33306391
The advocacy frontier.
Drew L. Drew L. Nature. 2021 Oct 27. doi: 10.1038/d41586-021-02926-4. Online ahead of print. Nature. 2021. PMID: 34707277 No abstract available.
Worm sensation!
Drew LJ, Wood JN. Drew LJ, et al. Mol Pain. 2005 Feb 15;1:8. doi: 10.1186/1744-8069-1-8. Mol Pain. 2005. PMID: 15813996 Free PMC article. Review. No abstract available.
The growth of tea.
Drew L. Drew L. Nature. 2019 Feb;566(7742):S2-S4. doi: 10.1038/d41586-019-00395-4. Nature. 2019. PMID: 30728512 No abstract available.
How athletes hit a fastball.
Drew L. Drew L. Nature. 2021 Apr;592(7852):S4-S6. doi: 10.1038/d41586-021-00816-3. Nature. 2021. PMID: 33790455 No abstract available.
208 results